NIH-funded research R21 grant

Understanding how specific brain circuits influence drug addiction and relapse

Official title: Control of drug-reward behavior and relapse vulnerability via a specialized serotonergic-septohippocampal circuit

Funded at Harvard Medical School · NIH-10869205 · Data updated 2026-11-12

This study is looking at how certain brain cells that make serotonin might help people recovering from addiction, like those trying to stay away from drugs, by influencing their memories and cravings for those substances.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 15, 2024
Project endJune 30, 2026
Funding year2024
Award (this year)$254,250
NIH project number1R21DA060373-01
Project IDNIH-10869205 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with a history of cocaine use who are currently in recovery and at risk of relapse.

Less likely to help

Patients who have not used cocaine or those who are not currently in recovery from substance use disorders may not benefit from this research.

What this research studies

This research investigates how certain brain neurons that produce serotonin affect the likelihood of relapse in individuals recovering from substance use disorders. By studying a specific type of serotonergic neuron, the researchers aim to understand how these neurons influence the memory of drug-related contexts and the motivation to seek drugs like cocaine. The approach involves examining the connections and functions of these neurons in various brain regions associated with memory and addiction. This could lead to new insights into how to better support individuals in recovery from addiction.

Why it matters

Potential benefit: If successful, this research could lead to improved strategies for preventing relapse in individuals recovering from substance use disorders.

How similar studies have gone: Previous research has shown promising results in understanding the role of serotonin in addiction, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Dymecki, Susan M. — Harvard Medical School
  • Study coordinator: Dymecki, Susan M.

Related research

Other NIH-funded projects on the same topics.

  • Social stress and smoking: why disadvantaged young adults struggle to quit

    This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.

    NIH research Medical University of South Carolina · Charleston, United States · NIH-11540695

  • Learning from remission and relapse in lupus (SLE)

    Researchers are studying people with systemic lupus erythematosus who are in long-term remission without steroids or immunosuppressants to understand their immune cells, brain function, and what might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513534

  • Learning from Remission and Relapse in SLE

    A program to study people with systemic lupus erythematosus who are in long-term remission to understand immune and brain signals that might predict relapse.

    NIH research Feinstein Institute for Medical Research · Manhasset, United States · NIH-11513533

  • Alternative NF-kB activation after chemotherapy in ovarian cancer

    This grant studies how ovarian cancer might come back after chemotherapy by looking at specific signaling pathways in cancer cells and the tumor environment.

    NIH research San Diego State University · San Diego, United States · NIH-11473227

  • Predictors of autoimmunity onset and relapse in skin

    A study to understand what biological signals in skin predict when autoimmune diseases start, flare, or worsen in people at risk.

    NIH research Massachusetts General Hospital · Boston, United States · NIH-11471389

  • Determinants of TB Control, Relapse, and Reinfection

    A large, multi-year study aims to understand why some people who are treated for TB still have persistent infection or relapse, with the goal of improving prevention and treatment.

    NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11449646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.